How many insider declarations does 昭衍新药 have?

昭衍新药 has filed 44 insider declarations with AMF.

Who is the top reporting insider at 昭衍新药?

The top reporting insider at 昭衍新药 is 左从林, based on the count of public filings.

What is the net insider buy vs sell volume on 昭衍新药?

Across the available history, declared buys total 0 and disposals 84k€.

InsidersTradesSigma

← Companies ★ Sign in to follow

昭衍新药: insider trades · France · AMF

SSE:603127FR·AMFMcap 24.3Bn€

AMF ↗

Discover the full management transaction log of 昭衍新药, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €24.3bn. The latest transaction was disclosed on 30 September 2025 (Sale). Among the most active insiders: 左从林. Every trade is free.

44

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

€84,498

43 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

39.17 €

Income statement

Revenue1.66 Bn€

Gross profit343.3 M€21% margin

Net income297.8 M€18.0% margin

Balance sheet & cash

Market cap24.27 Bn€

Total debt21.6 M€

Free Cash Flow301.0 M€

Last declaration on 30 September 2025

All Executives44 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations

About 昭衍新药

Zhaoyan New Drug is a company focused on the research and development of pharmaceuticals. It is listed on the XSHG market.